- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有323家主力机构披露2024-12-31报告期持股数据，持仓量总计2.90亿股，占流通A股51.05%
- 波段诊断：
-
技术面诊股
诊断结果：3.4技术面打败了33%的股票
技术面评分前10的股票
近期的平均成本为23.31元。
平均成本
近期的平均成本为23.31元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"23.31","date":1751876939,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2025.07.08","stock":false,"trade":"0.42","ind":"0.70"},{"date":"2025.07.07","stock":"0.00","trade":"-0.40","ind":"0.02"},{"date":"2025.07.04","stock":"-2.53","trade":"-0.36","ind":"0.32"},{"date":"2025.07.03","stock":"4.28","trade":"1.72","ind":"0.18"},{"date":"2025.07.02","stock":"3.07","trade":"-0.30","ind":"-0.09"},{"date":"2025.07.01","stock":"-0.97","trade":"1.61","ind":"0.39"},{"date":"2025.06.30","stock":"-0.09","trade":"0.30","ind":"0.59"},{"date":"2025.06.27","stock":"-0.04","trade":"0.38","ind":"-0.70"},{"date":"2025.06.26","stock":"-0.66","trade":"-0.51","ind":"-0.22"},{"date":"2025.06.25","stock":"1.11","trade":"0.24","ind":"1.03"},{"date":"2025.06.24","stock":"0.80","trade":"1.40","ind":"1.15"},{"date":"2025.06.23","stock":"-1.71","trade":"0.71","ind":"0.65"},{"date":"2025.06.20","stock":"-0.35","trade":"-0.05","ind":"-0.07"},{"date":"2025.06.19","stock":"1.23","trade":"-1.61","ind":"-0.79"},{"date":"2025.06.18","stock":"0.04","trade":"-1.39","ind":"0.04"},{"date":"2025.06.17","stock":"-0.76","trade":"-0.79","ind":"-0.04"},{"date":"2025.06.16","stock":"0.13","trade":"-0.34","ind":"0.35"},{"date":"2025.06.13","stock":"-3.19","trade":"-2.44","ind":"-0.75"},{"date":"2025.06.12","stock":"0.37","trade":"0.26","ind":"0.01"},{"date":"2025.06.11","stock":"0.00","trade":"0.22","ind":"0.52"},{"date":"2025.06.10","stock":"0.66","trade":"0.01","ind":"-0.44"}]
羚锐制药,上证指数,中药指数
压力支撑
该股压力位为23.39元，支撑位为23.06元。
[{"text":"\u538b\u529b\u4f4d","value":"23.39","date":1751904000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"23.06","date":1751904000,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了48%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月08日 17:20
| 机构今日流向(万元) | -675.92 | 机构5日流向(万元) | -2696.92 |
| 机构10日流向(万元) | -5162.10 | 机构20日流向(万元) | -19398.54 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少2404.41万股，其中基金净减仓59家，主力净减仓64家，请投资者中长期谨慎为宜。
截止2024-12-31，共323家主力机构（基金318家，一般法人2家，社保基金3家），持仓量总计28953.32万股，占流通A股51.05%
其中，基金持仓与2024-06-30相比：
增仓：47家 ，增持 1864.58万股
减仓：106家 ，减持 2688.24万股
新出现在主力名单中：150家 ，持有3963.67万股
从主力名单中消失：214家 ，原持有5128.22万股
其中，基金持仓与2024-06-30相比：
增仓：47家 ，增持 1864.58万股
减仓：106家 ，减持 2688.24万股
新出现在主力名单中：150家 ，持有3963.67万股
从主力名单中消失：214家 ，原持有5128.22万股
消息面诊股
诊断结果：6.1消息面打败了93%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 羚锐制药：7月7日获融资买入2640.02万元，占
2025-07-08 - 医药生物行业周报：商保目录将推出，新药上市在加快
2025-07-08 - 重磅！中国医药工业主营业务收入前100位企业发布（
2025-07-07 - 券商观点|医药生物行业跟踪周报：PD1/VEGF双
2025-07-07 - 行业追踪|中医药市场（6月30日-7月6日）：综合
2025-07-06 - 羚锐制药：7月4日获融资买入3052.43万元
2025-07-05 - 行业周报|中药指数涨2.99% 跑赢上证指数1.
2025-07-04 - 羚锐制药：7月3日获融资买入4657.89万元，占
2025-07-04 - 羚锐制药：7月2日获融资买入2471.60万元，占
2025-07-03 - 概念动态|羚锐制药新增“创新药”概念
2025-07-02
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-26 |
| 利好 | 分红转增 | 10派9.0元(含税) | 2025-04-26 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-26 |
| 一般消息 | 高管变动 | 因工作安排 | 2025-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-07 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-03-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了87%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.07.08","price":"0.70","value":"-0.40"},{"date":"2025.07.07","price":"0.02","value":"-0.36"},{"date":"2025.07.04","price":"0.32","value":"1.72"},{"date":"2025.07.03","price":"0.18","value":"-0.30"},{"date":"2025.07.02","price":"-0.09","value":"1.61"},{"date":"2025.07.01","price":"0.39","value":"0.30"},{"date":"2025.06.30","price":"0.59","value":"0.38"},{"date":"2025.06.27","price":"-0.70","value":"-0.51"},{"date":"2025.06.26","price":"-0.22","value":"0.24"},{"date":"2025.06.25","price":"1.03","value":"1.40"},{"date":"2025.06.24","price":"1.15","value":"0.71"},{"date":"2025.06.23","price":"0.65","value":"-0.05"},{"date":"2025.06.20","price":"-0.07","value":"-1.61"},{"date":"2025.06.19","price":"-0.79","value":"-1.39"},{"date":"2025.06.18","price":"0.04","value":"-0.79"},{"date":"2025.06.17","price":"-0.04","value":"-0.34"},{"date":"2025.06.16","price":"0.35","value":"-2.44"},{"date":"2025.06.13","price":"-0.75","value":"0.26"},{"date":"2025.06.12","price":"0.01","value":"0.22"},{"date":"2025.06.11","price":"0.52","value":"0.01"},{"date":"2025.06.10","price":"-0.44","value":"2.07"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华森制药 | 174.55% | -0.18% | 4.0分 |
| 2 | 佛慈制药 | 169.11% | 1.68% | 5.1分 |
| 3 | 嘉应制药 | 52.37% | 2.06% | 5.5分 |
| 4 | 贵州百灵 | 28.50% | -3.51% | 5.0分 |
| 5 | 启迪药业 | 14.08% | 1.65% | 4.2分 |
| 6 | 康惠制药 | 12.22% | 9.15% | 5.4分 |
| 8 | 佐力药业 | 8.14% | 5.22% | 5.5分 |
| 10 | - | 4.39% | 4.39% | 分 |
| 12 | 济川药业 | 2.34% | -1.90% | 4.7分 |
| 14 | 珍宝岛 | 1.56% | 0.00% | 4.5分 |
| 16 | 羚锐制药 | 1.07% | 3.75% | 5.4分 |
| 18 | 太龙药业 | 0.85% | 5.90% | 4.9分 |
| 20 | 新光药业 | 0.39% | 0.53% | 4.5分 |
| 22 | 康恩贝 | 0.23% | 1.60% | 5.0分 |
| 24 | 以岭药业 | -0.07% | 3.74% | 5.2分 |
| 26 | 益盛药业 | -0.25% | 0.63% | 4.6分 |
| 28 | 维康药业 | -0.71% | 1.33% | 3.9分 |
| 30 | 白云山 | -0.94% | 0.23% | 5.3分 |
| 32 | 汉森制药 | -1.06% | 1.72% | 4.7分 |
| 34 | 新天药业 | -1.13% | 0.73% | 4.0分 |
| 36 | 葵花药业 | -1.31% | -0.13% | 3.7分 |
| 38 | 千金药业 | -1.48% | 2.69% | 5.2分 |
| 40 | 上海凯宝 | -2.19% | 1.13% | 5.0分 |
| 42 | 达仁堂 | -2.67% | 1.25% | 5.1分 |
| 44 | 片仔癀 | -2.90% | -1.38% | 5.0分 |
| 46 | 江中药业 | -3.36% | 0.27% | 4.9分 |
| 48 | ST香雪 | -4.26% | 0.12% | 4.0分 |
| 50 | 众生药业 | -4.39% | 3.07% | 4.4分 |
| 52 | 健民集团 | -5.13% | -0.46% | 4.7分 |
| 54 | 华润三九 | -5.98% | -0.29% | 4.7分 |
| 56 | 方盛制药 | -6.21% | 4.58% | 4.9分 |
| 58 | 马应龙 | -7.18% | -3.57% | 4.5分 |
| 60 | 昆药集团 | -8.75% | -0.21% | 4.4分 |
| 62 | - | -21.92% | -3.26% | 分 |
| 64 | 步长制药 | - | 2.03% | 4.8分 |
| 66 | 中恒集团 | - | 4.35% | 4.2分 |
| 68 | 仁和药业 | - | 1.66% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/112 ， 6/112。
[{"date":"2025-03-31","value":"6.79","vol":"2.23"},{"date":"2024-12-31","value":"24.65","vol":"5.32"},{"date":"2024-09-30","value":"20.19","vol":"2.95"},{"date":"2024-06-30","value":"15.04","vol":"1.60"},{"date":"2024-03-31","value":"6.65","vol":"1.67"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.79 | 24.65 | 20.19 | 15.04 | 6.65 |
| 行业(%) | 2.23 | 5.32 | 2.95 | 1.60 | 1.67 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"76.77","vol":"53.01"},{"date":"2024-12-31","value":"75.82","vol":"52.47"},{"date":"2024-09-30","value":"75.00","vol":"52.77"},{"date":"2024-06-30","value":"76.04","vol":"53.17"},{"date":"2024-03-31","value":"75.60","vol":"53.62"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
76.77 | 75.82 | 75.00 | 76.04 | 75.60 |
| 行业(%) | 53.01 | 52.47 | 52.77 | 53.17 | 53.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/112 ， 16/112。
[{"date":"2025-03-31","value":"12.29","vol":"-5.22"},{"date":"2024-12-31","value":"5.72","vol":"-6.80"},{"date":"2024-09-30","value":"10.07","vol":"-4.36"},{"date":"2024-06-30","value":"12.07","vol":"-4.12"},{"date":"2024-03-31","value":"15.27","vol":"-2.27"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
12.29 | 5.72 | 10.07 | 12.07 | 15.27 |
| 行业(%) | -5.22 | -6.80 | -4.36 | -4.12 | -2.27 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"13.89","vol":"-35.55"},{"date":"2024-12-31","value":"27.19","vol":"-101.25"},{"date":"2024-09-30","value":"23.10","vol":"-6.00"},{"date":"2024-06-30","value":"30.30","vol":"-15.66"},{"date":"2024-03-31","value":"31.98","vol":"-9.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.89 | 27.19 | 23.10 | 30.30 | 31.98 |
| 行业(%) | -35.55 | -101.25 | -6.00 | -15.66 | -9.41 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/112 ， 30/112。
[{"date":"2025-03-31","value":"0.20","vol":"0.12"},{"date":"2024-12-31","value":"0.72","vol":"0.49"},{"date":"2024-09-30","value":"0.57","vol":"0.37"},{"date":"2024-06-30","value":"0.40","vol":"0.26"},{"date":"2024-03-31","value":"0.19","vol":"0.13"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.72 | 0.57 | 0.40 | 0.19 |
| 行业(次) | 0.12 | 0.49 | 0.37 | 0.26 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.58","vol":"0.62"},{"date":"2024-12-31","value":"1.88","vol":"2.41"},{"date":"2024-09-30","value":"1.55","vol":"1.80"},{"date":"2024-06-30","value":"1.01","vol":"1.24"},{"date":"2024-03-31","value":"0.48","vol":"0.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 1.88 | 1.55 | 1.01 | 0.48 |
| 行业(次) | 0.62 | 2.41 | 1.80 | 1.24 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"11.52","vol":"2.34"},{"date":"2024-12-31","value":"70.89","vol":"15.76"},{"date":"2024-09-30","value":"6.97","vol":"6.40"},{"date":"2024-06-30","value":"24.64","vol":"11.96"},{"date":"2024-03-31","value":"4.94","vol":"1.49"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 11.52 | 70.89 | 6.97 | 24.64 | 4.94 |
| 行业 | 2.34 | 15.76 | 6.40 | 11.96 | 1.49 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.51","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.44","vol":"1.38"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.51 | - | 0.44 | - |
| 行业 | 0.00 | 1.45 | 0.00 | 1.38 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/112 ， 18/112。
[{"date":"2025-03-31","value":"1.01","vol":"2.97"},{"date":"2024-12-31","value":"1.31","vol":"2.87"},{"date":"2024-09-30","value":"1.18","vol":"3.19"},{"date":"2024-06-30","value":"1.08","vol":"2.92"},{"date":"2024-03-31","value":"1.49","vol":"2.96"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.01 | 1.31 | 1.18 | 1.08 | 1.49 |
| 行业 | 2.97 | 2.87 | 3.19 | 2.92 | 2.96 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.65","vol":"2.19"},{"date":"2024-12-31","value":"0.92","vol":"2.09"},{"date":"2024-09-30","value":"0.84","vol":"2.38"},{"date":"2024-06-30","value":"0.77","vol":"2.20"},{"date":"2024-03-31","value":"1.14","vol":"2.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.65 | 0.92 | 0.84 | 0.77 | 1.14 |
| 行业 | 2.19 | 2.09 | 2.38 | 2.20 | 2.26 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 16/112 ， 21/112。
[{"date":"2025-03-31","value":"38.20","vol":"33.51"},{"date":"2024-12-31","value":"38.60","vol":"34.19"},{"date":"2024-09-30","value":"40.61","vol":"33.21"},{"date":"2024-06-30","value":"42.49","vol":"34.04"},{"date":"2024-03-31","value":"40.95","vol":"33.28"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
38.20 | 38.60 | 40.61 | 42.49 | 40.95 |
| 行业(%) | 33.51 | 34.19 | 33.21 | 34.04 | 33.28 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.62","vol":"0.73"},{"date":"2024-12-31","value":"0.63","vol":"0.75"},{"date":"2024-09-30","value":"0.69","vol":"3.21"},{"date":"2024-06-30","value":"0.74","vol":"1.65"},{"date":"2024-03-31","value":"0.70","vol":"0.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.62 | 0.63 | 0.69 | 0.74 | 0.70 |
| 行业(%) | 0.73 | 0.75 | 3.21 | 1.65 | 0.98 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 首创证券 | 2025-06-26 | 买入 | |
| 西部证券 | 2025-05-30 | 增持 | |
| 国泰海通证券 | 2025-05-20 | 买入 | |
| 东海证券 | 2025-05-13 | 买入 | |
| 招商证券 | 2025-05-09 | 买入 | |
| 国联民生 | 2025-05-07 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.62","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.65","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.23","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.35","blueLineValue":"1.47","type":"YC"}]